Sec Form 4 Filing - CHARDAN CAPITAL MARKETS LLC @ ANEW Medical, Inc. - 2024-06-28

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
CHARDAN CAPITAL MARKETS LLC
2. Issuer Name and Ticker or Trading Symbol
ANEW Medical, Inc. [ WENA]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
ONE PENNSYLVANIA PLAZA, SUITE 4800
3. Date of Earliest Transaction (MM/DD/YY)
06/28/2024
(Street)
NEW YORK, NY10119
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/28/2024 S 47,000 D $ 2.5341 ( 1 ) 1,579,500 D ( 2 )
Common Stock 07/01/2024 S 115,136 D $ 2.0638 ( 3 ) 1,464,364 D ( 2 )
Common Stock 07/02/2024 S 180,000 D $ 2.0469 ( 4 ) 1,284,364 D ( 2 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Cod e V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
CHARDAN CAPITAL MARKETS LLC
ONE PENNSYLVANIA PLAZA, SUITE 4800
NEW YORK, NY10119
X
Chardan Securities LLC
ONE PENNSYLVANIA PLAZA, SUITE 4800
NEW YORK, NY10119
X
GROSSMAN JONAS
1 EAST PUTMAN AVENUE, 4TH FLOOR
GREENWICH, CT06830
X
Urbach Steven
ONE PENNSYLVANIA PLAZA, SUITE 4800
NEW YORK, NY10119
X
PROPPER KERRY
ONE PENNSYLVANIA PLAZA, SUITE 4800
NEW YORK, NY10119
X
Signatures
Chardan Capital Markets LLC, By: /s/ Steven Urbach, Manager 07/02/2024
Signature of Reporting Person Date
Chardan Securities LLC, By: /s/ Steven Urbach, Manager 07/02/2024
Signature of Reporting Person Date
/s/ Jonas Grossman 07/02/2024
Signature of Reporting Person Date
/s/ Steven Urbach 07/02/2024
Signature of Reporting Person Date
/s/ Kerry Propper 07/02/2024
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.38 to $2.71, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
( 2 )This Form 4 is being filed by Chardan Capital Markets LLC ("CCM"). Chardan Securities LLC ("Chardan Securities") is the sole Class A Member and 99% owner of CCM and as such has voting and investment discretion with respect to the Common Stock held of record by CCM and may be deemed to have beneficial ownership of the Common Stock held directly by CCM. Each of Jonas Grossman, Steven Urbach and Kerry Propper is a member of Chardan Securities, and as such has voting and investment discretion with respect to the Common Stock held of record by CCM and may be deemed to have beneficial ownership of the Common Stock held directly by CCM. Each of Mr. Grossman, Mr. Urbach and Mr. Propper disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
( 3 )The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.80 to $2.495, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
( 4 )The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.90 to $2.30, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.